Dolby Laboratories Inc. [DLB] stock Reiterated by B. Riley FBR analyst, price target now $73

Dolby Laboratories Inc. [NYSE: DLB] gained 1.64% on the last trading session, reaching $75.08 price per share at the time.

Dolby Laboratories Inc. represents 100.59 million in outstanding shares, while the company has a total market value of $7.43 billion with the latest information. DLB stock price has been found in the range of $73.40 to $75.15.

If compared to the average trading volume of 434.18K shares, DLB reached a trading volume of 1116007 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Dolby Laboratories Inc. [DLB]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DLB shares is $76.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DLB stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

B. Riley FBR have made an estimate for Dolby Laboratories Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 04, 2020. While these analysts kept the previous recommendation, B. Riley FBR raised their target price from $68 to $72. The new note on the price target was released on June 24, 2020, representing the official price target for Dolby Laboratories Inc. stock. Previously, the target price had yet another raise from $57 to $60, while B. Riley FBR kept a Buy rating on DLB stock.

The Average True Range (ATR) for Dolby Laboratories Inc. is set at 1.64, with the Price to Sales ratio for DLB stock in the period of the last 12 months amounting to 6.25. The Price to Book ratio for the last quarter was 3.11, with the Price to Cash per share for the same quarter was set at 10.55. Price to Free Cash Flow for DLB in the course of the last twelve months was 36.50 with Quick ratio for the last quarter at 5.70.

Trading performance analysis for DLB stock

Dolby Laboratories Inc. [DLB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.68. With this latest performance, DLB shares gained by 12.87% in over the last four-week period, additionally plugging by 28.30% over the last 6 months – not to mention a rise of 16.71% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DLB stock in for the last two-week period is set at 67.89, with the RSI for the last a single of trading hit 76.42, and the three-weeks RSI is set at 66.00 for Dolby Laboratories Inc. [DLB]. The present Moving Average for the last 50 days of trading for this stock 68.13, while it was recorded at 72.73 for the last single week of trading, and 64.67 for the last 200 days.

Dolby Laboratories Inc. [DLB]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Dolby Laboratories Inc. [DLB] shares currently have an operating margin of +23.65 and a Gross Margin at +87.04. Dolby Laboratories Inc.’s Net Margin is presently recorded at +20.55.

Return on Total Capital for DLB is now 13.02, given the latest momentum, and Return on Invested Capital for the company is 11.35. Return on Equity for this stock inclined to 11.35, with Return on Assets sitting at 9.30.

Reflecting on the efficiency of the workforce at the company, Dolby Laboratories Inc. [DLB] managed to generate an average of $116,348 per employee. Receivables Turnover for the company is 4.73 with a Total Asset Turnover recorded at a value of 0.45.Dolby Laboratories Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.70 and a Current Ratio set at 5.80.

Dolby Laboratories Inc. [DLB]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, Dolby Laboratories Inc. posted 0.43/share EPS, while the average EPS was predicted by analysts to be reported at 0.48/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -10.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DLB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Dolby Laboratories Inc. go to 16.00%.

An analysis of insider ownership at Dolby Laboratories Inc. [DLB]

There are presently around $4,508 million, or 94.00% of DLB stock, in the hands of institutional investors. The top three institutional holders of DLB stocks are: VANGUARD GROUP INC with ownership of 5,895,499, which is approximately -0.994% of the company’s market cap and around 0.50% of the total institutional ownership; JANUS HENDERSON GROUP PLC, holding 4,437,649 shares of the stock with an approximate value of $333.18 million in DLB stocks shares; and CLEARBRIDGE INVESTMENTS, LLC, currently with $299.02 million in DLB stock with ownership of nearly -4.817% of the company’s market capitalization.

Positions in Dolby Laboratories Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 130 institutional holders increased their position in Dolby Laboratories Inc. [NYSE:DLB] by around 5,327,242 shares. Additionally, 175 investors decreased positions by around 5,965,783 shares, while 45 investors held positions by with 48,750,485 shares. The mentioned changes placed institutional holdings at 60,043,510 shares, according to the latest SEC report filing. DLB stock had 42 new institutional investments in for a total of 2,547,250 shares, while 43 institutional investors sold positions of 785,601 shares during the same period.

Share on facebook
Share on twitter
Share on linkedin
Share on skype
Share on reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam